Table 1 Clinical and biochemical variables of the study population

Age (years)

42.05 ± 7.96

− 12.85 to (− 6.39)

< 0.0001

BMI (kg/m²)

28.23 ± 4.84

− 7.35 to 4.97

0.9241

SBP (mmHg)

135.16 ± 19.98

− 15.71 to (− 0.92)

0.0288

DBP (mmHg)

74. 54 ± 13.51

47.17 to 56.41

0.0001

FBG (mmol/L)

5.03 ± 0.61

− 8.56 to (− 4.62)

< 0.0001

T. Chol (mmol/L)

4.58 ± 0.65

− 1.76 to (− 1.33)

< 0.0001

TG (mmol/L)

1.04 ± 0.43

− 0.79 to (− 0.26)

0.0001

HDL (mmol/L)

1.26 ± 0.47

− 0.15 to 0.15

1.0000

LDL (mmol/L)

2.85 ± 0.86

− 1.12 to (− 0.53)

0.0001

Cardiovascular risk

3.54 ± 1.38

− 1.79 to (− 0.88)

0.0001

Atherogenic index

3.18 ± 0.08

− 2.96 to (− 2.45)

< 0.0001

Total Bil (μmol/L)

13.75 ± 4.97

− 0.40 to 4.26

0.1065

Direct Bil (μmol/L)

4.35 ± 2.53

− 0.79 to 0.65

0.8509

Indirect Bil (μmol/L)

9.39 ± 3.92

0.40 to 2.93

0.0105

GGT (U/L)

30.43 ± 11.58

− 5.04 to 5.20

0.9756

ALT (U/L)

27.85 ± 9.49

− 12.85 to (− 1.53)

0.0138

AST (U/L)

30.36 ± 7.27

− 3.93 to (− 0.54)

0.0805

ALP (U/L)

177.50 ± 52.69

− 24.54 to 13.90

0.5882

Total protein (g/L)

68.35 ± 10.06

− 1.774 to 6.934

0.2473

Albumin (g/L)

38.60 ± 5.87

− 1.87 to 2.43

0.7990

Duration of DM (years)

–

–

–